Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia

Leukemia and Lymphoma

Volumn 43, Issue 11, 2002, Pages 2083-2092

  Saif, Muhammad Wasif ^a   Hopkins, Jon L ^b   Gore, Steven D ^c  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Autoimmune phenomena; Connective tissue disorder; Leukemia; Myelodysplastic syndrome; Paraneoplastic manifestations; Vasculitis

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MEPREDNISONE; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; PREDNISONE; STEROID; THYMOCYTE ANTIBODY; TOPOTECAN;

ADULT; AGED; ARTHRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNITY; CANCER PATIENT; CASE REPORT; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; COOMBS TEST; DISEASE COURSE; DRUG MEGADOSE; DRUG RESPONSE; ENTERITIS; FEMALE; FEVER; GLOMERULONEPHRITIS; HEMATOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INCIDENCE; LUNG INFILTRATE; MALE; MYELODYSPLASTIC SYNDROME; PATHOGENESIS; POLYNEUROPATHY; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; RELAPSING POLYCHONDRITIS; REVIEW; SKIN DISEASE; SPLENECTOMY; STEM CELL TRANSPLANTATION; SYMPTOMATOLOGY; SYSTEMIC VASCULITIS; TREATMENT OUTCOME; IMMUNOLOGY; MIDDLE AGED; PARANEOPLASTIC SYNDROME; SYNDROME;

ADULT; AGED; AUTOIMMUNE DISEASES; AUTOIMMUNITY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PARANEOPLASTIC SYNDROMES; SYNDROME;

EID: 0036838704     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819021000016186     Document Type: Review

References (36)

1. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnik, H.R. and Sultan, C. (1982) "The French-American-British (FAB) Cooperative Group. Proposals for the classification of the myelodysplastic syndromes", British Journal of Haematology 51, 189-199.
2. Mijovic, A. and Mufti, G.J. (1998) "The MDS: towards a functional classification", Blood Reviews 12, 73-83.
3. Heaney, M.L. and Golde, D.W. (1999) "Myelodysplasia", The New England Journal of Medicine 340, 1649-1660.
4. Harris, N.L., Jaffe, E.S., Diebold, J. and Flandrin, G. (1999) "WHO Classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the clinical advisory committee meeting-Airlie House, Virginia, November 1997", JCO 17, 3835-3849.
5. Enright, H., Jacob, H.S., Vercellotti, G., Howe, R., Belzer, M. and Miller, W. (1995) "Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy", British Journal of Haematology 91, 403-408.
6. Colombat, P.H., Renoux, M., Lamagnere, J.P. and Renoux, G. (1988) "Immunologic indicers in myelodysplastic syndromes", Cancer 61, 1075-1081.
7. Green, A.R., Shuttleworth, D., Bowen, D.T. and Bentley, D.P. (1990) "Cutaneous vasculitis in patients with myelodysplastia", British Journal of Haematology 74, 364-365.
8. Fernandez-Miranda, C., Garcia-Marcilla, A. and Martin, M. (1994) "Vasculitis associated with a MDS: a report of 5 cases", Medicina Clinica 103, 539-542.
9. Pagliuca, A., Higgins, E., Samson, D., Humphries, S. and Mufti, G.J. (1990) "Prodromal cutaneous vasculitis in myelodysplastic syndromes", British Journal of Haematology 75, 444-446.
10. Doutre, M.S., Beylot, J., Beylot, C., Courouge-Dorcier, D., Reiffers, J., Brouster, A. and Bioulac-Sage, P. (1987) "Refractory anemia with an excess of blast and cutaneous vasculitis", Annals of Dermatology and Venereology 114, 97-100.
11. Savige, J.A., Chang, L., Smith, C.L. and Duggan, J.C. (1993) "Myelodysplasia, vasculitis and anti-neutrophil cytoplasm anti-bodies", Leukemia and Lymphoma 9, 49-54.
12. George, S.W. and Newman, E.D. (1992) "Seronegative inflammatory arthritis in the myelodysplastic syndromes", Seminars in Arthritis and Rheumatism 21, 345-354.
13. Castro, M., Conn, D.L., Su, W.P. and Garton, J.P. (1992) "Rheumatic manifestations in myelodysplastic syndromes", Journal of Rheumatology 721, 727.
14. Marullo, S., Dallot, A., Cavelier-Balloy, B., Valensi, F. and Clauvel, J.P. (1989) "Prodromal cutaneous vasculitis in myelodysplastic syndromes", British Journal of Haematology 75, 444-446.
15. Ramakrishna, R. and Chaudri, K. (1992) "Hematological manifestations of primary Sjogren's Syndrome: a clinicopathological study", Quarterly Journal of Medicine 83, 547-554.
16. McGill, J., Michet, C., Goldberg, J., Pedell, L. and McAdam, L. (1986) "Relapsing polychondritis and hematopoietic disease in 11 patients", Arthritis and Rheumatism 39, 1898.
17. Hebbar, M., Brouillard, M., Wattel, E., Decoulx, M., Hatron, P.Y., Devulder, B. and Fenaux, P. (1995) "Association of myelodysplastic syndrome and relapsing polychondritis: further evidence", Leukemia 9, 731-733.
18. Ng, H.S., Ng, H.W., Sinniah, R. and Feng, RH. (1981) "A case of systemic lupus erythematosis with sideroblastic anaemia terminating in erythroleukemia", Annals of the Rheumatic Diseases 40, 422-426.
19. Sokol, R.J., Hewitt, S. and Booker, D.J. (1989) "Erythrocyte autoantibodies, autoimmune hemolysis, and MDS", Journal of Clinical Pathology 42, 1088-1091.
20. Stadtmauer, E.A. (1991) "Danazol treatment of MDS", British Journal of Haematology 77, 502-508.
21. Van Rhee, F. and Abela, M. (1991) "Coombs negative haemolytic anaemia responding to intravenous immunoglobulins in a patient with myelodysplastic syndrome", Clinics in Laboratory Haematology 13(1), 99-101.
22. Tamura, S., Konya, H. and Miyazaki, E. (1991) "Coombs negative autoimmune hemolytic anemia in a patient with MDS", Rirsho Ketsueki 32, 13-136.
23. Ecoromopoulos, T. and Economidou, J. (1985) "Immune abnormalities in MDS", Journal of Clinical Pathology 38, 908-911.
24. Mufti, G.J. and Figes, A. (1986) "I. Serum immunoglobulins and autoantibodies", British Journal of Haematology 63, 143-147.
25. Karchen, D.S. and Frost, A.R. (1991) "The bone marrow in HIV-related disease. Morphology and clinical correlation", American Journal of Clinical Pathology 95, 63-71.
26. Billstrom, R., Johansson, H. and Johansson, B. (1995) "Immune-mediated complications in patients with MDS", European Journal of Hematology 55, 44-48.
27. Bagby, G.C., Gabourel, J.D. and Linman, J.W. (1980) "Glucocoticoid therapy in the preleukemic syndrome: identification of responsive patients by invitrotechniques", Annals of Internal Medicine 92, 55-58.
28. de Witte, T., Suciu, S. and Peetermans, M. (1995) "Intensive chemotherapy for poor prognosis MDS and secondary AML following MDS of > 6 months duration: a pilot study by EORTC-LCG", Leukemia 9, 1805-1811.
29. Estey, E., Thall, P., Beran, M., Kantarjian, H., Pierce, S. and Keating, M. (1997) "Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy", Blood 90, 2969-2977.
30. Molldrem, J.J., Caples, M. and Mavroudis, D. (1997) "Antithymocyte globulin for patients with MDS", British Journal of Haematology 99, 699-705.
31. Jonasova, A., Newwirtova, R. and Cermak, J. (1998) "Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anemias without hypoplastic bone marrow", British Journal of Haematology 100, 304-309.
32. Caron, P.C., Dumont, L. and Scheinberg, D.A. (1998) "Supersaturating infusional humanized anti-CD33 monoclonal antibody HUM 195 im myclogenous leukemia", Clinics in Cancer Research 4, 1421-1428.
33. Anderson, J.E., Appelbaum, F.R. and Storb, R. (1995) "An update on allogeneic marrow transplantation for MDS", Leukemia and Lymphoma 17, 95-99.
34. Appelbaum, F.R. and Anderson, J. (1998) "Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS score", Leukemia 12(Suppl. 1), S25-S29.
35. Delforge, M., Demuynck, H. and Vandenberghe, P. (1995) "Polyclonal primitive hematopoietic progenitors can be detected in mobilized peripheral blood from patients with high-risk MDS", Blood 86, 3660-3667.
36. de Witte, T., Van Biezen, A. and Hermans, J. (1997) "Autologous bone marrow transplantation or patients with MDS or AML following MDS", Blood 90, 3853-3857.